Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA.

Publication ,  Journal Article
Rasmussen, RV; Fowler, VG; Skov, R; Bruun, NE
Published in: Future Microbiol
January 2011

Staphylococcus aureus bacteremia (SAB) is an urgent medical problem due to its growing frequency and its poor associated outcome. As healthcare delivery increasingly involves invasive procedures and implantable devices, the number of patients at risk for SAB and its complications is likely to grow. Compounding this problem is the growing prevalence of methicillin-resistant S. aureus (MRSA) and the dwindling efficacy of vancomycin, long the treatment of choice for this pathogen. Despite the recent availability of several new antibiotics for S. aureus, new strategies for treatment and prevention are required for this serious, common cause of human infection.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Future Microbiol

DOI

EISSN

1746-0921

Publication Date

January 2011

Volume

6

Issue

1

Start / End Page

43 / 56

Location

England

Related Subject Headings

  • Vancomycin
  • Staphylococcal Infections
  • Microbiology
  • Methicillin-Resistant Staphylococcus aureus
  • Livestock
  • Humans
  • Endocarditis
  • Cross Infection
  • Bacteremia
  • Anti-Bacterial Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rasmussen, R. V., Fowler, V. G., Skov, R., & Bruun, N. E. (2011). Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. Future Microbiol, 6(1), 43–56. https://doi.org/10.2217/fmb.10.155
Rasmussen, Rasmus V., Vance G. Fowler, Robert Skov, and Niels E. Bruun. “Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA.Future Microbiol 6, no. 1 (January 2011): 43–56. https://doi.org/10.2217/fmb.10.155.
Rasmussen RV, Fowler VG, Skov R, Bruun NE. Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. Future Microbiol. 2011 Jan;6(1):43–56.
Rasmussen, Rasmus V., et al. “Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA.Future Microbiol, vol. 6, no. 1, Jan. 2011, pp. 43–56. Pubmed, doi:10.2217/fmb.10.155.
Rasmussen RV, Fowler VG, Skov R, Bruun NE. Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. Future Microbiol. 2011 Jan;6(1):43–56.
Journal cover image

Published In

Future Microbiol

DOI

EISSN

1746-0921

Publication Date

January 2011

Volume

6

Issue

1

Start / End Page

43 / 56

Location

England

Related Subject Headings

  • Vancomycin
  • Staphylococcal Infections
  • Microbiology
  • Methicillin-Resistant Staphylococcus aureus
  • Livestock
  • Humans
  • Endocarditis
  • Cross Infection
  • Bacteremia
  • Anti-Bacterial Agents